AI Agent Governance for Pharmacy Prior Authorization Denials

Why Prior Authorization Agents Require Distinct Governance

Pharmacy prior authorization is one of the first high-volume healthcare workflows where AI agents are being given operational authority rather than advisory input alone. These agents commonly interact with claims adjudication systems, formulary and benefit databases, clinical criteria engines, and provider or EHR data feeds. Each of these integrations represents a distinct permission surface, and the risk profile changes substantially depending on whether the agent has read-only access or write access that can issue a denial code.

Most existing healthcare AI compliance content addresses model accuracy, clinical logic, or bias in training data. That is necessary but insufficient. An agent can be clinically accurate in its reasoning and still act outside its authorized scope if it is permitted to call a tool or finalize a determination it was never approved to execute autonomously. Governance for this workflow has to address agent behavior at runtime, not just the quality of the underlying model.

What Regulators Currently Require

CMS finalized the Interoperability and Prior Authorization Final Rule (CMS-0057-F), which requires impacted payers to issue prior authorization decisions within 72 hours for urgent requests and 7 calendar days for standard requests, and to include a specific reason when denying a request. Starting with reporting due in 2026, impacted payers must also report annual metrics including approval and denial rates.

Separately, CMS's Medicare Advantage guidance is explicit that automated systems cannot be the sole basis for an adverse determination. Final decisions based on clinical information must involve review by a qualified healthcare professional, and any algorithm or AI tool used to assist utilization management must be applied consistently with Medicare coverage criteria rather than overriding individualized clinical assessment.

Several states, including California and Colorado, have enacted or advanced legislation in the past year restricting insurers from using AI or algorithms as the sole basis for denying, delaying, or modifying care. HHS Section 1557 guidance additionally requires covered health programs to identify and mitigate discriminatory impact from AI and clinical decision-support tools.

None of these sources specify the technical mechanism for enforcing these requirements. They establish the compliance obligation, not the runtime architecture. That architecture is left to the deploying organization to design and validate.

Runtime Permission Risks Specific to This Workflow

OWASP's guidance on LLM applications identifies excessive agency and insecure plugin or tool design as primary risk categories for agents that can invoke external functions. In a prior authorization context, this translates into a concrete distinction: an agent that can read formulary data or retrieve clinical criteria carries materially lower risk than one that can write to a claims system or transmit a denial determination.

Granting broad system access to simplify integration work creates a governance gap that is difficult to detect after deployment, because the agent's actions may appear correct in aggregate while individual actions exceed the intended policy boundary. The mitigation OWASP recommends, and that applies directly here, is scoped tool permissions defined per workflow step, combined with human-in-the-loop checkpoints at points where the agent's output could become a final adverse action.

Audit Logging and Traceability Requirements

CMS's reporting obligations for denial rationale and reason codes imply that agent architectures must capture structured decision rationale at the point of determination, not just the final output shown to a reviewer. NIST's AI Risk Management Framework and its Generative AI Profile identify traceability as a core function for managing AI system risk, specifically calling out the need to track and document inputs, outputs, and decision logic to support incident response and auditability.

For a prior authorization agent, this means logging what clinical criteria version was referenced, what data sources were retrieved, what rationale the agent generated, and what human reviewer, if any, acted on the output. Logs built only around the final denial or approval will not satisfy either the traceability expectation in NIST's framework or the practical need to reconstruct a decision during an audit or state inquiry.